Tricuspid atresia secondary prevention

Tricuspid atresia Microchapters
Home
Patient Information
Overview
Pathophysiology
Causes
Differentiating Tricuspid Atresia from other Disorders
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography
Cardiac Catheterization
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Special Scenarios
Pregnancy
Case Studies
Case #1
Tricuspid atresia secondary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Tricuspid atresia secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Tricuspid atresia secondary prevention
CDC on Tricuspid atresia secondary prevention
Tricuspid atresia secondary prevention in the news
Blogs on Tricuspid atresia secondary prevention
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Tricuspid atresia secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Keri Shafer, M.D. [2] Priyamvada Singh, MBBS [[3]]; Assistant Editor-In-Chief: Kristin Feeney, B.S. [[4]]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Secondary Prevention

ACC/AHA 2008 Guidelines - Recommendations for Endocarditis Prophylaxis - Tricuspid atresia (DO NOT EDIT)

Class IIa

"1.Antibiotic prophylaxis before dental procedures that involve manipulation of gingival tissue or the periapical region of teeth or perforation of the oral mucosa is reasonable in those patients with the following indications: "

"a.Prosthetic cardiac valve.(Level of Evidence: B)"

"b.Previous infective endocarditis (IE).(Level of Evidence: B)"

"c.Unrepaired and palliated cyanotic CHD, including surgically constructed palliative shunts and conduits.(Level of Evidence: B)"

"d.Completely repaired CHD with prosthetic materials, whether placed by surgery or catheter intervention, during the first 6 months after the procedure.(Level of Evidence: B)"

"e.Repaired CHD with residual defects at the site or adjacent to the site of a prosthetic patch or prosthetic device that inhibit endothelialization.(Level of Evidence: B)"

"2.It is reasonable to consider antibiotic prophylaxis against IE before vaginal delivery at the time of membrane rupture in select patients with the highest risk of adverse outcomes. This includes patients with the following indications:"

"a.Prosthetic cardiac valve or prosthetic material used for cardiac valve repair.(Level of Evidence: C)"

"b.Unrepaired and palliated cyanotic CHD, including surgically constructed palliative shunts and conduits.(Level of Evidence: C)"

Class III

"1.Prophylaxis against IE is not recommended for nondental procedures (such as esophagogastroduodenoscopy or colonoscopy) in the absence of active infection.(Level of Evidence: C) "